BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9215240)

  • 1. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract.
    Nelson HS; Lahr J; Rule R; Bock A; Leung D
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):744-51. PubMed ID: 9215240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of peanut allergy with rush immunotherapy.
    Oppenheimer JJ; Nelson HS; Bock SA; Christensen F; Leung DY
    J Allergy Clin Immunol; 1992 Aug; 90(2):256-62. PubMed ID: 1500630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis--a study using IgE and IgG4 immunoblot monitoring.
    Bullock RJ; Barnett D; Howden ME
    Allergol Immunopathol (Madr); 2005; 33(5):250-6. PubMed ID: 16287543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food allergy to peanuts in France--evaluation of 142 observations.
    Moneret-Vautrin DA; Rance F; Kanny G; Olsewski A; Gueant JL; Dutau G; Guerin L
    Clin Exp Allergy; 1998 Sep; 28(9):1113-9. PubMed ID: 9761015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
    Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
    Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.
    Michaud E; Evrard B; Pereira B; Rochette E; Bernard L; Rouzaire PO; Gourdon-Dubois N; Merlin E; Fauquert JL
    Trials; 2015 Apr; 16():197. PubMed ID: 25925398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
    Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.
    Anagnostou K; Clark A; King Y; Islam S; Deighton J; Ewan P
    Clin Exp Allergy; 2011 Sep; 41(9):1273-81. PubMed ID: 21414048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
    Syed A; Garcia MA; Lyu SC; Bucayu R; Kohli A; Ishida S; Berglund JP; Tsai M; Maecker H; O'Riordan G; Galli SJ; Nadeau KC
    J Allergy Clin Immunol; 2014 Feb; 133(2):500-10. PubMed ID: 24636474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
    Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
    Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful oral tolerance induction in severe peanut allergy.
    Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW
    Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study.
    Maina E; Pelst M; Hesta M; Cox E
    BMC Vet Res; 2017 Jan; 13(1):25. PubMed ID: 28100257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy.
    Pagovich OE; Wang B; Chiuchiolo MJ; Kaminsky SM; Sondhi D; Jose CL; Price CC; Brooks SF; Mezey JG; Crystal RG
    J Allergy Clin Immunol; 2016 Dec; 138(6):1652-1662.e7. PubMed ID: 27372563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy.
    Nagakura KI; Sato S; Yanagida N; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Int Arch Allergy Immunol; 2018; 175(3):181-188. PubMed ID: 29339650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
    Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
    Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival provocation test in diagnosis of peanut allergy in children.
    Lindvik H; Lødrup Carlsen KC; Mowinckel P; Navaratnam J; Borres MP; Carlsen KH
    Clin Exp Allergy; 2017 Jun; 47(6):785-794. PubMed ID: 28160326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AR101 Oral Immunotherapy for Peanut Allergy.
    ; Vickery BP; Vereda A; Casale TB; Beyer K; du Toit G; Hourihane JO; Jones SM; Shreffler WG; Marcantonio A; Zawadzki R; Sher L; Carr WW; Fineman S; Greos L; Rachid R; Ibáñez MD; Tilles S; Assa’ad AH; Nilsson C; Rupp N; Welch MJ; Sussman G; Chinthrajah S; Blumchen K; Sher E; Spergel JM; Leickly FE; Zielen S; Wang J; Sanders GM; Wood RA; Cheema A; Bindslev-Jensen C; Leonard S; Kachru R; Johnston DT; Hampel FC; Kim EH; Anagnostou A; Pongracic JA; Ben-Shoshan M; Sharma HP; Stillerman A; Windom HH; Yang WH; Muraro A; Zubeldia JM; Sharma V; Dorsey MJ; Chong HJ; Ohayon J; Bird JA; Carr TF; Siri D; Fernández-Rivas M; Jeong DK; Fleischer DM; Lieberman JA; Dubois AEJ; Tsoumani M; Ciaccio CE; Portnoy JM; Mansfield LE; Fritz SB; Lanser BJ; Matz J; Oude Elberink HNG; Varshney P; Dilly SG; Adelman DC; Burks AW
    N Engl J Med; 2018 Nov; 379(21):1991-2001. PubMed ID: 30449234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.